Global (United States, European Union and China) Diabetic Eye Disease Devices Market Research Report 2019-2025

SKU ID : QYR-14560563 | Publishing Date : 15-Aug-2019 | No. of pages : 118

Diabetes eye diseases consist of a group of eye-related conditions that affect individuals with diabetes. The conditions include diabetic macular edema (DME), diabetic retinopathy, glaucoma, and cataract. Diabetes is the leading cause of eye diseases and can cause severe vision loss or blindness. These eye diseases are widely treated with laser surgery.
The growing adoption of minimally invasive (MI) surgeries is one of the key growth drivers of the global diabetic eye disease devices market. As MI surgeries cause minimal scarring and have improved surgical outcomes, there is a significant reduction in the duration of hospital stay. Most retinal surgeries these days are carried out using an MI small gauge surgery that does not require sutures. Moreover, the MI surgical procedures are performed using the right-sized instruments that reduce post-operative discomfort. This results in facilitating rapid healing without changing the refractive power of the eye. Therefore, the MI approach is used in several retinal surgeries such as for the treatment of retinal detachment, macular holes, macular puckers, and diabetic maculopathy. The growing preference for minimally invasive retinal surgeries is expected to positively affect the market in the coming years.
The global diabetic eye disease devices market is highly competitive and characterized by the technological advancements and innovation. The market has several small and regional vendors developing strategic alliances with global players to gain market share. Factors like increased product portfolio extensions, advances in technology, and R&D have resulted in intense competition among vendors. The competition is expected to intensify with vendors using innovative marketing strategies to gain market presence.
The Americas to dominate the market and hold the largest market share of more than 55%. The US is the largest revenue generator in this region. According to the IDF estimates, 30 million people in the US had diabetes, which was the highest among 38 developed nations. Due to the increasing number of people with diabetes, there has been increasing incidences of eye disorders among the older population. Factors such as the recent technological advancements and awareness of laser eye surgeries will propel this market’s growth in the Americas.
In 2019, the market size of Diabetic Eye Disease Devices is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Diabetic Eye Disease Devices.

This report studies the global market size of Diabetic Eye Disease Devices, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Diabetic Eye Disease Devices production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Alcon Inc.
Ellex Medical Lasers Ltd.
IRIDEX Corp.
Synergetics USA Inc.
Topcon Corp. 
 Abbott Medical Optics
Bausch & Lomb
Carl Zeiss Meditec
Lumenis
Meridian
NIDEK
Quantel
Rhein Medical 

Market Segment by Product Type
Laser surgery
Vitrectomy

Market Segment by Application
Hospitals
Clinics and laboratories
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Diabetic Eye Disease Devices status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Diabetic Eye Disease Devices manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Diabetic Eye Disease Devices are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
PRICE
3280
6560

4920


  • market Reports market Reports